Article
Alteration on NO-production in the cochlea of the guinea pig after intratympanic Gentamicin application
Search Medline for
Authors
Published: | August 8, 2007 |
---|
Outline
Text
Introduction: Gentamicin application is an essential therapeutic option for Menière’s disease. Despite given gentamicin at intervals, a destruction of the cochlea was often observed and assumed to be the result of an increased NO-production in the inner ear. The presented study was undertaken to identify any correlation between application of gentamicin, the spatiotemporal destruction pattern and the regions of altered NO-production in the cochlea.
Materials and methods: A single dosage of Gentamicin (10 mg/kg body weight) was injected intratympanally to male guinea pigs and the acoustic evoked potentials (AEPs) were recorded before treatment and 1, 2, and 7 days after application. The organ of Corti and the lateral wall were removed from the bulla, incubated separately for six hours in cell culture medium and the degree of NO-production was determined by chemiluminescence.
Results: Gentamicin application resulted in a reduction of the hearing threshold at the second day after treatment. In the organ of Corti, the amount of NO-production remained nearly unchanged, but two days after gentamicin application an increased NO-production was found in the lateral wall.
Discussion: The correlation between the alteration in hearing threshold shift and the increased NO-production in the lateral wall favors the idea that gentamicin might influence potassium recycling processes and thus contributes to the disturbance of the cochlear ion homeostasis.